Disc Medicine Sells $720k: CFO Moves After FDA Rejection
A biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Regular budget reviews involve quick weekly checks and a deeper monthly audit to refine categories and improve long-term financial health.
14,490 articlesA biotech insider trade draws attention after an FDA setback. This article unpacks the CFO's $720k stock sale at Disc...
Geopolitical turmoil and potential chokepoint disruptions raise the odds of a renewed oil shock. Markets bracing $100...
Stocks moved sharply in both directions on Tuesday as investors weighed the risk of broader conflict in the Middle Ea...
When the broader market fell, one name stood out. This article explains why plug power stock defied the downturn, fea...
On Holding's stock has caught the eye of many long-term investors who pay attention to fundamentals rather than short...
In a turbulent market, five Dividend Kings have continuously raised payouts for more than half a century, underscorin...
A new memoir and interview place Lloyd Blankfein at the center of a renewed debate over risk, accountability, and how...
Three AWS data centers in the UAE and Bahrain were hit by Iranian drones, causing widespread outages in finance and d...
PennyMac’s Third-Party Origination unit rolls out a seven-program non-QM suite to broaden options for borrowers with ...
March 2026 brings a crowded field of Seeking Alpha alternatives. Traders now weigh real-time data, crowd insights, an...
Oil climbs to the upper $90s per barrel as defense spending expands and aviation MRO demand stays tight. Analysts say...
A year of dramatic moves has put Dave (DAVE) on investors' radar. A newly disclosed $7 million stake from a prominent...